EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Risk-Based Quality Management: A Case for Centralized Monitoring

Nicole Stansbury, Danilo Branco, Cris McDavid, Jennifer Stewart, Kristin Surdam, Nycole Olson, Joanne Perry, Jeremy Liska, Linda Phillips, Amanda Coogan, Anina Adelfio, Lauren Garson

Therapeutic Innovation & Regulatory Science · 2025

DOI: 10.1007/s43441-024-00719-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Innovation & Regulatory Science, 2025. Verfasst von Nicole Stansbury und 11 weiteren Autor:innen. Beteiligte Einrichtung: Association of Clinical Research Organizations (ACRO), 601 New Jersey Ave NW #350, Washington DC, 20001, USA. Hauptthemen laut MEDLINE: Risk Management, Clinical Trials as Topic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since 2019, the Association of Clinical Research Organizations has conducted a landscape survey of risk based quality management (RBQM) adoption in clinical trials. Here, we present data from four years of surveys, with an emphasis on the most recent: the 2022 survey included data from 4958 trials across seven contract research organizations, of which 1004 were new studies started in 2022. Results indicate that while overall risk assessment adoption is strong, it is lagging in other risk-based components which suggests companies are not deriving the full expected benefits of performing a risk assessment and mitigation process to their trials. The 2022 study also suggests new study starts showing promising traction, with adoption hovering near 50% for most RBQM elements. At the same time, the survey suggests industry has mixed views on the potential value of quality tolerance limits (QTLs). Ultimately, centralized monitoring is being underutilized despite the potential of increased patient safety oversight and improved data quality. The authors of this paper developed a case study based on a trial in clinicaltrials.gov to demonstrate how RBQM adoption could include the key RBQM elements such as centralized monitoring, reduced source data review and source data verification as well as implementation of QTLs in a real-world scenario. The authors believe the clinical trial industry has an obligation to utilize centralized monitoring to produce more efficient and effective clinical trials and will make a case to do so in this paper.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Risk ManagementClinical Trials as TopicHumansRisk AssessmentSurveys and Questionnaires

Stichwörter der Autor:innen

Centralized monitoringClinical trial qualityRBMRBQMRisk-based monitoringRisk-based quality management

Autor:innen und Institutionen

  • Association of Clinical Research Organizations (ACRO), 601 New Jersey Ave NW #350, Washington DC, 20001, USA.
  • Association of Clinical Research Organizations (ACRO), 601 New Jersey Ave NW #350, Washington DC, 20001, USA. AAdelfio@acrohealth.org.

Zitieren

APA

Stansbury, N., Branco, D., McDavid, C., Stewart, J., Surdam, K., Olson, N., Perry, J., Liska, J., Phillips, L., Coogan, A., Adelfio, A., & Garson, L. (2025). Risk-Based Quality Management: A Case for Centralized Monitoring. Therapeutic Innovation & Regulatory Science. https://doi.org/10.1007/s43441-024-00719-1

Vancouver

Stansbury N, Branco D, McDavid C, Stewart J, Surdam K, Olson N, et al. Risk-Based Quality Management: A Case for Centralized Monitoring. Therapeutic Innovation & Regulatory Science. 2025. doi:10.1007/s43441-024-00719-1

BibTeX
@article{Stansbury2025,
  author = {Stansbury, Nicole and Branco, Danilo and McDavid, Cris and Stewart, Jennifer and Surdam, Kristin and Olson, Nycole and Perry, Joanne and Liska, Jeremy and Phillips, Linda and Coogan, Amanda and Adelfio, Anina and Garson, Lauren},
  title = {Risk-Based Quality Management: A Case for Centralized Monitoring},
  journal = {Therapeutic Innovation & Regulatory Science},
  year = {2025},
  doi = {10.1007/s43441-024-00719-1}
}
Kostenlos starten →